Table of Contents 1 Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Overview 1.1 Product Overview and Scope of Focal Segmental Glomerulosclerosis (FSGS) Treatment 1.2 Classification of Focal Segmental Glomerulosclerosis (FSGS) Treatment by Types 1.2.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Comparison by Types (2017-2023) 1.2.2 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Types in 2017 1.2.3 Drug Therapy 1.2.4 Dialysis 1.2.5 Kidney Transplant 1.3 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market by Application 1.3.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size and Market Share Comparison by Applications (2013-2023) 1.3.2 Primary FSGS 1.3.3 Secondary FSGS 1.4 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market by Regions 1.4.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size (Million USD) Comparison by Regions (2013-2023) 1.4.1 North America (USA, Canada and Mexico) Focal Segmental Glomerulosclerosis (FSGS) Treatment Status and Prospect (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Focal Segmental Glomerulosclerosis (FSGS) Treatment Status and Prospect (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Focal Segmental Glomerulosclerosis (FSGS) Treatment Status and Prospect (2013-2023) 1.4.4 South America (Brazil, Argentina, Colombia) Focal Segmental Glomerulosclerosis (FSGS) Treatment Status and Prospect (2013-2023) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Focal Segmental Glomerulosclerosis (FSGS) Treatment Status and Prospect (2013-2023) 1.5 Global Market Size of Focal Segmental Glomerulosclerosis (FSGS) Treatment (2013-2023) 2 Manufacturers Profiles 2.1 B. Braun Melsungen 2.1.1 Business Overview 2.1.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 B. Braun Melsungen Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.2 Medtronic 2.2.1 Business Overview 2.2.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Medtronic Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.3 Pfizer 2.3.1 Business Overview 2.3.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Pfizer Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.4 Complexa 2.4.1 Business Overview 2.4.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Complexa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.5 Dimerix 2.5.1 Business Overview 2.5.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Dimerix Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.6 Retrophin 2.6.1 Business Overview 2.6.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Retrophin Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.7 Beckman Coulter Inc. (Danaher) 2.7.1 Business Overview 2.7.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Beckman Coulter Inc. (Danaher) Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.8 Boston Scientific Corporation 2.8.1 Business Overview 2.8.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Boston Scientific Corporation Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.9 ChemoCentryx 2.9.1 Business Overview 2.9.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 2.10 Variant Pharmaceuticals 2.10.1 Business Overview 2.10.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) 3 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Competition, by Players 3.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Share by Players (2013-2018) 3.2 Market Concentration Rate 3.2.1 Top 5 Focal Segmental Glomerulosclerosis (FSGS) Treatment Players Market Share 3.2.2 Top 10 Focal Segmental Glomerulosclerosis (FSGS) Treatment Players Market Share 3.3 Market Competition Trend 4 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size by Regions 4.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Market Share by Regions 4.2 North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 4.3 Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 4.4 Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 4.5 South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 4.6 Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 5 North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries 5.1 North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries (2013-2018) 5.2 USA Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 5.3 Canada Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 5.4 Mexico Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 6 Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries 6.1 Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries (2013-2018) 6.2 Germany Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 6.3 UK Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 6.4 France Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 6.5 Russia Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 6.6 Italy Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 7 Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries 7.1 Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries (2013-2018) 7.2 China Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 7.3 Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 7.4 Korea Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 7.5 India Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 7.6 Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 8 South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries 8.1 South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries (2013-2018) 8.2 Brazil Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 8.3 Argentina Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 8.4 Colombia Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 9 Middle East and Africa Revenue Focal Segmental Glomerulosclerosis (FSGS) Treatment by Countries 9.1 Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries (2013-2018) 9.2 Saudi Arabia Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 9.3 UAE Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 9.4 Egypt Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 9.5 Nigeria Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 9.6 South Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) 10 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Segment by Type 10.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Market Share by Type (2013-2018) 10.2 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Forecast by Type (2018-2023) 10.3 Drug Therapy Revenue Growth Rate (2013-2023) 10.4 Dialysis Revenue Growth Rate (2013-2023) 10.5 Kidney Transplant Revenue Growth Rate (2013-2023) 11 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Segment by Application 11.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Application (2013-2018) 11.2 Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Forecast by Application (2018-2023) 11.3 Primary FSGS Revenue Growth (2013-2018) 11.4 Secondary FSGS Revenue Growth (2013-2018) 12 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2018-2023) 12.1 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Size Forecast (2018-2023) 12.2 Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Forecast by Regions (2018-2023) 12.3 North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) 12.4 Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) 12.5 Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) 12.6 South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) 12.7 Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Focal Segmental Glomerulosclerosis (FSGS) Treatment Picture Table Product Specifications of Focal Segmental Glomerulosclerosis (FSGS) Treatment Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Types in 2017 Figure Drug Therapy Picture Figure Dialysis Picture Figure Kidney Transplant Picture Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) by Application (2013-2023) Figure Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Applications in 2017 Figure Primary FSGS Picture Figure Secondary FSGS Picture Table Global Market Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) Comparison by Regions 2013-2023 Figure North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) and Growth Rate (2013-2023) Table B. Braun Melsungen Basic Information, Manufacturing Base and Competitors Table B. Braun Melsungen Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table B. Braun Melsungen Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Medtronic Basic Information, Manufacturing Base and Competitors Table Medtronic Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table Medtronic Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table Pfizer Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Complexa Basic Information, Manufacturing Base and Competitors Table Complexa Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table Complexa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Dimerix Basic Information, Manufacturing Base and Competitors Table Dimerix Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table Dimerix Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Retrophin Basic Information, Manufacturing Base and Competitors Table Retrophin Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table Retrophin Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Beckman Coulter Inc. (Danaher) Basic Information, Manufacturing Base and Competitors Table Beckman Coulter Inc. (Danaher) Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table Beckman Coulter Inc. (Danaher) Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors Table Boston Scientific Corporation Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table Boston Scientific Corporation Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table ChemoCentryx Basic Information, Manufacturing Base and Competitors Table ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Variant Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Treatment Type and Applications Table Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue, Gross Margin and Market Share (2016-2017) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) by Players (2013-2018) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Players (2013-2018) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Players in 2016 Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Players in 2017 Figure Global Top 5 Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share in 2017 Figure Global Top 10 Players Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share in 2017 Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) by Regions (2013-2018) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Regions (2013-2018) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Regions (2013-2018) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Regions in 2017 Figure North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Table North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries (2013-2018) Table North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries (2013-2018) Figure North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries (2013-2018) Figure North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries in 2017 Figure USA Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Canada Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Mexico Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Table Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) by Countries (2013-2018) Figure Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries (2013-2018) Figure Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries in 2017 Figure Germany Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure UK Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure France Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Russia Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Italy Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Table Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) by Countries (2013-2018) Figure Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries (2013-2018) Figure Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries in 2017 Figure China Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Japan Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Korea Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure India Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Table South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Countries (2013-2018) Table South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries (2013-2018) Figure South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries (2013-2018) Figure South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries in 2017 Figure Brazil Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Argentina Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Colombia Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Table Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) by Countries (2013-2018) Table Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share by Countries in 2017 Figure Saudi Arabia Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure UAE Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Egypt Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure Nigeria Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Figure South Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue and Growth Rate (2013-2018) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) by Type (2013-2018) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Type (2013-2018) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Type (2013-2018) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Type in 2017 Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Forecast by Type (2018-2023) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share Forecast by Type (2018-2023) Figure Global Drug Therapy Revenue Growth Rate (2013-2018) Figure Global Dialysis Revenue Growth Rate (2013-2018) Figure Global Kidney Transplant Revenue Growth Rate (2013-2018) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue by Application (2013-2018) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Application (2013-2018) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Application (2013-2018) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Share by Application in 2017 Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Forecast by Application (2018-2023) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Market Share Forecast by Application (2018-2023) Figure Global Primary FSGS Revenue Growth Rate (2013-2018) Figure Global Secondary FSGS Revenue Growth Rate (2013-2018) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023) Table Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue (Million USD) Forecast by Regions (2018-2023) Figure Global Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Share Forecast by Regions (2018-2023) Figure North America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) Figure Europe Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) Figure Asia-Pacific Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) Figure South America Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023) Figure Middle East and Africa Focal Segmental Glomerulosclerosis (FSGS) Treatment Revenue Market Forecast (2018-2023)

B. Braun Melsungen Medtronic Pfizer Complexa Dimerix Retrophin Beckman Coulter Inc. (Danaher) Boston Scientific Corporation ChemoCentryx Variant Pharmaceuticals